XRAY continues to gain traction from a robust product portfolio. However, the macroeconomic factors, such as weakened global demand, persist.

Tariff situation remains fluid and dynamic and uncertainty in the dental industry remains high. Our long-term sales assumption relies on continued innovation from the firm—which allocates 4% of sales ...

Dentsply Sirona (XRA) stock turns lower as Morgan Stanley downgrades to Equal Weight amid macro challenges, innovation concerns, and tariff risks. Read more here.

Being chosen as a KOL by Dentsply Sirona is an honor and a responsibility to lead dentistry through education and innovation," said Dr. Saad. "Empowering patients and peers is my mission.” Dr. Radwa ...

The dental biomaterials market is projected to grow at a CAGR of ~8% over the forecast period. Major factors driving the growth include the increasing prevalence of dental disorders, growing demand ...

DENTSPLY SIRONA Inc. has a 1-year low of $14.78 and ... Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising ...

Detailed price information for Align Technology (ALGN-Q) from The Globe and Mail including charting and trades.

DENTSPLY SIRONA’s payout ratio is -14.07% ... Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging ...

Mr. Susino has held executive roles at leading healthcare companies, including Dentsply Sirona, Henry Schein, LifeScan, and The Straumann Group. Most recently, he led the global implant and ...

Align, Dentsply, and Sirona all rely on consumer demand to drive sales, and especially sales of surgical consumables, implants, and aligners, so the depressed patient volume will hurt near-term ...